<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
    <title><![CDATA[EU/3/17/1873 (Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,15,15'-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-.alpha.-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide); where two identical synthetic peptide domains are covalently linked at the ends of the polyethylene glycol chain) - Best Regulatory Consulting Ltd]]></title>
    <ttl>1440</ttl>
    <copyright>Copyright: (C) European Commission</copyright>
    <language>en-gb</language>
    <atom:link href="http://ec.europa.eu/health/documents/community-register/html/rss/o1873.rss" rel="self" type="application/rss+xml" />
    <lastBuildDate>Tue, 23 May 2017 12:05:00 +0000</lastBuildDate>
    <link>http://ec.europa.eu/health/documents/community-register/html/o1873.htm</link>
    <description><![CDATA[EU/3/17/1873 (Active substance: Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,15,15'-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-.alpha.-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide); where two identical synthetic peptide domains are covalently linked at the ends of the polyethylene glycol chain) - EU number: EU/3/17/1873 - Marketing authorisation holder: Best Regulatory Consulting Ltd]]>
    </description>
    <image>
        <title><![CDATA[EU/3/17/1873 (Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,15,15'-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-.alpha.-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide); where two identical synthetic peptide domains are covalently linked at the ends of the polyethylene glycol chain) - Best Regulatory Consulting Ltd]]></title>
        <url>http://ec.europa.eu/health/documents/community-register/images/logo_en.gif</url>
        <link>http://ec.europa.eu/health/documents/community-register/html/o1873.htm</link>
        <width>144</width>
        <height>100</height>
    </image>
    <item>
        <title>Orphan designation - Commission Decision (2017)3606 of Tue, 23 May 2017</title>
        <category>New documents</category>
        <guid isPermaLink="true">http://ec.europa.eu/health/documents/community-register/html/o1873.htm#proc137942</guid>
        <link>http://ec.europa.eu/health/documents/community-register/html/o1873.htm#proc137942</link>
        <description><![CDATA[Orphan designation) - Commission Decision (2017)3606 of Tue, 23 May 2017 - European Medicines Agency (EMA) procedure number: EMA/OD/004/17]]></description>
        <pubDate>Tue, 23 May 2017 12:05:00 +0000</pubDate>
    </item>
    </channel>
</rss>
